Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Infection

The Presence of Clostridioides difficile in Stool Samples of Children with Cystic Fibrosis

  • Read more about The Presence of Clostridioides difficile in Stool Samples of Children with Cystic Fibrosis

Inflammation and infection change what mucus is made of, how much gets made, and how much it can dissolve

  • Read more about Inflammation and infection change what mucus is made of, how much gets made, and how much it can dissolve

How does infection with Pseudomonas and Aspergillus affect people with cystic fibrosis? A study using UK registry data.

  • Read more about How does infection with Pseudomonas and Aspergillus affect people with cystic fibrosis? A study using UK registry data.

Environmental risks of Pseudomonas aeruginosa-What to advise patients and parents

  • Read more about Environmental risks of Pseudomonas aeruginosa-What to advise patients and parents

Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis

  • Read more about Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis

Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis

  • Read more about Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis

Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells.

  • Read more about Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells.

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.

  • Read more about Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.

Ceftaroline Pharmacokinetics and Pharmacodynamics in Patients with Cystic Fibrosis

  • Read more about Ceftaroline Pharmacokinetics and Pharmacodynamics in Patients with Cystic Fibrosis

Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.

  • Read more about Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.
  • 1
  • 2
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)